James Goodwin, MD

James Goodwin, MD

Associate Professor of Ophthalmology
Neuro-Ophthalmology Service

Mailing Address:
Illinois Eye and Ear Infirmary
1855 W. Taylor Street, M/C 648
Chicago, IL 60612
Email: jamegood@uic.edu

Sees patients at:
Neuro-Ophthalmology Service
Illinois Eye and Ear Infirmary
1855 W. Taylor Street, Suite 3.158
Clinic Phone: (312) 996-9120


request and appointment

"Dr. Goodwin was very thorough and extremely friendly and patient. 
He is the best!" comment from PatientExperience.net

Dr. Goodwin joined the Illinois Eye and Ear Infirmary in 1985 as Director of the Neuro-Ophthalmology Service, a position he held until 2011. He is a consulting neurologist at Jesse Brown Veterans Administration Medical Center and John H. Stroger, Jr. Hospital of Cook County. He has been involved in several major multi-center clinical trials including the Optic Nerve Treatment Trial and the Ischemic Optic Neuropathy Decompression Trial. Dr. Goodwin is board certified in neurology.


Patient Testimonials


 Best Doctors logo   Patient Thank You Letters


BS—Northwestern University, Illinois
MD—University of Illinois College of Medicine at Chicago
Residency in Neurology—University of Minnesota Medical School
Clinical Fellowship in Neuro-Ophthalmology—Bascom Palmer Eye Institute, University of Miami

See a collection of Dr. Goodwin's publications on PubMed.

Recent Publications

Mahdi N, Faia LJ, Goodwin J, Nussenblatt RB, Sen HN. A case of autoimmune retinopathy associated with thyroid carcinoma. Ocul Immunol Inflamm. 2010 Aug;18(4):322-3. doi: 10.3109/09273941003802379. PubMed PMID: 20662664.

Keltner JL, Johnson CA, Cello KE, Dontchev M, Gal RL, Beck RW; Optic Neuritis Study Group. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. Arch Ophthalmol. 2010 Mar;128(3):330-7. doi: 10.1001/archophthalmol.2010.16. PubMed PMID: 20212204.

Biousse V, Calvetti O, Drews-Botsch CD, Atkins EJ, Sathornsumetee B, Newman NJ; Optic Neuritis Survey Group. Management of optic neuritis and impact of clinical trials: an international survey. J Neurol Sci. 2009 Jan  15;276(1-2):69-74. doi: 10.1016/j.jns.2008.08.039. Epub 2008 Oct 16. PubMed PMID: 18926549.

Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol. 2008 Jun;65(6):727-32. doi: 10.1001/archneur.65.6.727. PubMed PMID: 18541792; PubMed Central PMCID: PMC2440583.

Bhatt HK, Goodwin JA. Pneumocephalus following macular hole repair. Arch Ophthalmol. 2007 Nov;125(11):1583-4. PubMed PMID: 17998530.

Optic Neuritis Study Group. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Ophthalmology. 2008 Jun;115(6):1079-1082.e5. Epub 2007 Nov 5. PubMed PMID: 17976727.

Kupersmith MJ, Gal RL, Beck RW, Xing D, Miller N; Optic Neuritis Study Group. Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome. Neurology. 2007 Aug 7;69(6):508-14. Erratum in: Neurology. 2008 Feb 26;70(9):738. PubMed PMID: 17679669.

Goodwin J. Autoimmune optic neuropathy. Curr Neurol Neurosci Rep. 2006 Sep;6(5):396-402. Review. PubMed PMID: 16928350.

Zhu Y, Thulborn K, Curnyn K, Goodwin J. Sixth cranial nerve palsy caused by compression from a dolichoectatic vertebral artery. J Neuroophthalmol. 2005 Jun;25(2):134-5. PubMed PMID: 15937439.

Goodwin J. Recent developments in idiopathic intracranial hypertension (IIH). Semin Ophthalmol. 2003 Dec;18(4):181-9. Review. PubMed PMID: 15513004.